Causes of death in patients with unresectable hepatocellular carcinoma

Digestive Diseases and Sciences

Volumn 52, Issue 11, 2007, Pages 3285-3289

  Couto, O F M ^a   Dvorchik, I ^a   Carr, B I ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Death; Hepatocellular carcinoma; Survival

Indexed keywords

CISPLATIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; SEPSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, HEPATOCELLULAR; CAUSE OF DEATH; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34848854859     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9750-3     Document Type: Article

References (15)

1. Varela M, Sala M, Llovet JM, Bruix J (2003) Natural history and prognostic prediction of patients with hepatocellular carcinoma. Aliment Pharmacol Ther 17 (Suppl 2):98-102
2. Parkin DM, Bray F, Ferlay J, Pisani P (2000) Estimating the world cancer burden: GLOBOCAN. Int J Cancer 94:153-156
3. Bosch X, Ribes J, Borràs J (1999) Epidemiology of primary liver cancer. Semin Liver Dis 19:271-285
4. El Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745-750
5. Collier J, Sherman M (1998) Screening for hepatocellular carcinoma. Hepatology 27:273-278
6. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362(9399):1907-1917
7. Bruix J, Llovet JM (2002) Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35:519-524
8. Befeler AS, Di Bisceglie AM (2002) Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 122:1609-1619
9. Llovet JM, Beaugrand M (2003) Hepatocellular carcinoma: present status and future prospects. J Hepatol 38 (Suppl 1):S136-S149
10. Bruix J, Sherman M, Llovet JM, et al (2001) Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-EASL Conference. J Hepatol 35:421-430
11. The Liver Cancer Study Group of Japan (1994) Predictive factors for long-term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 74:2272-2280
12. Tsukuma H, Hiyama T, Tanaka S, et al (1993) Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328:1797-1801
13. Okuda K, Ohtsuki T, Obata H, et al (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients. Cancer 56:918-928
14. Kaczynsky J, Hansson G, Wallerstedt W (1995) Metastases in cases with hepatocellular carcinoma in relation to clinicopathologic features of the tumor. Acta Oncol 34(1):43-48
15. Carr BI (2002) Hepatic artery chemoembolization for advanced-stage HCC: experience of 650 patients. Hepatogastroenterology 49:79-86